Understanding Luminal Microorganisms and Their Potential Effectiveness in Treating Intestinal Inflammation

M. Nedim Ince, Bruce R. Blazar, Michael B. Edmond, Guido Tricot, Michael J. Wannemuehler

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations


The human intestine contains 10 14 bacteria, which outnumber the mammalian cells 10-fold. Certain other commensal or infectious agents, like helminthic parasites, become members of this microbial ecosystem, especially in populations living under less hygienic conditions. Intestinal microbes, also called the microbiome or microbiota, shape the host immune reactivity to self and nonself throughout life. Changes in microbiome composition may impair the maturation of immune regulatory pathways and predispose the host to develop various forms of inflammatory disorders, like Crohn's disease or ulcerative colitis. The microbiome is also critical to successful transplantation of organs or grafts. After allogeneic hematopoietic stem cell transplantation, when the new donor cells, such as T lymphocytes learn to discriminate "the new self from nonself" in the transplant recipient, they need healthy microbiota-derived signals to preserve the immune homeostasis. Restoring microbiota through intestinal delivery of bacterial strains, helminths, fecal microbiota transplantation, or stool substitutes have the potential to improve and correct aberrant immune reactivity in various disorders.

Original languageEnglish (US)
Pages (from-to)194-201
Number of pages8
JournalInflammatory bowel diseases
Issue number1
StatePublished - Jan 1 2016

Bibliographical note

Publisher Copyright:
© 2015 Crohn's & Colitis Foundation of America, Inc.


  • graft-versus-host disease
  • inflammatory bowel disease
  • regulatory T cell and fecal microbiota transplantation


Dive into the research topics of 'Understanding Luminal Microorganisms and Their Potential Effectiveness in Treating Intestinal Inflammation'. Together they form a unique fingerprint.

Cite this